Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suc-HSA in Treatment Naïve HIV-1 Infected Subjects
NCT00128063Phase 2Completed
- Sponsor
- International Antiviral Therapy Evaluation Center
- Start
- Aug 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of succinylated human serum albumin in human immunodeficiency virus infection (HIV), sponsored by International Antiviral Therapy Evaluation Center. Primary endpoint: Pharmacokinetics (Cmin, Cmax, AUC) at week 2. Started Aug 2005; status: completed.
02
Drugs
succinylated human serum albumin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00128063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00128063.